Use of the selective serotonin reuptake inhibitor citalopram in the treatment of generalized social phobia

Journal of Affective Disorders

Volumn 49, Issue 1, 1998, Pages 79-82

  Bouwer, Colin ^a   Stein, Dan J ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Citalopram; Serotonin; Social phobia

Indexed keywords

CITALOPRAM; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE CLASSIFICATION; DRUG RESPONSE; DRUG SCREENING; FEMALE; HEADACHE; HUMAN; MALE; NAUSEA; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; RATING SCALE; SEXUAL DYSFUNCTION; SLEEP DISORDER; SOCIAL PHOBIA; TREATMENT OUTCOME;

ADULT; CITALOPRAM; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOBIC DISORDERS; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0032053389     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(97)00182-1     Document Type: Article

References (30)

1. Black B., Uhde T.W., Tancer M.E. Fluoxetine for the treatment of social phobia. J. Clin. Psychopharmacol. 12:1992;293-295.
2. Davidson J.R.T., Potts N., Richichi E.et al. Treatment of social phobia with clonazepam and placebo. J. Clin. Psychopharmacol. 13:1993;423-428.
3. Davidson J.R.T., Tupler L.A., Potts N.L.S. Treatment of social phobia with benzodiazepines. J. Clin. Psychiatry. 55S:1994;28-32.
4. Davidson R.T., Hughes D.C., George L.K., Blazer D.G. The boundary of social phobia: Exploring the threshold. Arch. Gen. Psychiatry. 51:1994;975-983.
5. Gelernter C.S., Uhde T.W., Cimbolic P.et al. Cognitive-behavioral and pharmacological treatments of social phobia: A controlled study. Arch. Gen. Psychiatry. 48:1991;938-945.
6. Guy W. (Ed.) ECDEU Assessment Manual for Psychopharmacology, revised. US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, MD: National Institute of Mental Health, 1976.
7. Hyttel J. Pharmacological characterization of selective serotonin reuptake inhibitors. Int. Clin. Psychopharmacol. 9S:1994;19-26.
8. The International Multicenter Clinical Trial Group on Moclobemide in Social Phobia. Moclobemide in social phobia: A double-blind, placebo controlled study. Eur. Arch. Psychiatry Clin. Neurosci. 1997;247:71-80.
9. Katzelnick D.J., Kobak K.A., Greist J.H.et al. Sertraline for social phobia: a double-blind, placebo-controlled crossover study. Am. J. Psychiatry. 152:1995;1368-1371.
10. Kessler R.G., McGonagle K.A., Zhao S.et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch. Gen. Psychiatry. 51:1994;8-19.
11. Lepola U., Koponen H., Leinonen E. Citalopram in the treatment of social phobia: a report of three cases. Pharmacopsychiatry. 27:1994;186-188.
12. Liebowitz M.R., Social phobia. In: Ban T.A., Pichot P., Poldinger W. (Eds.). Modern Problems of Pharmacopsychiatry. Basel, Karger, 1987.
13. Liebowitz M.R., Schneier F., Campeas R.et al. Phenelzine vs. atenolol in social phobia: a placebo-controlled comparison. Arch. Gen. Psychiatry. 49:1992;290-300.
14. Martins E.A., Piggott T.A., Bernstein S.E., et al: Sertraline in the treatment of patients with social phobia. Anxiety 1994/1995;1:291-297.
15. Mancini C., van Ameringen M. Paroxetine in social phobia. J. Clin. Psychiatry. 57:1996;519-522.
16. Montgomery S.A., Pedersen V., Tanghoj P., Rasmussen P., Rioux P. The optimal dosing regime for citalopram - a meta-analysis of nine placebo-controlled studies. Int. Clin. Psychopharmacol., 9S:1994;35-40.
17. Munjack D.J., Flowers C., Eagan T.V., Sertraline in social phobia. Anxiety 1994/1995;1:196-198.
18. Safren S.A., Heimberg R.G., Brown E.J., Holle C., Quality of life in social phobia. Depression and Anxiety 1996/1997;4:126-133.
19. Stein M.B., Walker J.R., Forde D.R. Setting diagnostic thresholds for social phobia: considerations from a community survey of social anxiety. Am. J. Psychiatry. 151:1994;408-412.
20. Schneier F.R., Johnson J., Hornig C.D., Liebowitz M.R., Weissman M.M. Social phobia: comorbidity and morbidity in an epidemiologic sample. Arch. Gen. Psychiatry. 49:1992;282-288.
21. Schneier F.R., Chin S.J., Hollander E., Liebowitz M.R. Fluoxetine in social phobia. J. Clin. Psychopharmacol. 12:1992;62-64.
22. Schneier F.R., Heckelman L., Garfinkel R.et al. Functional impairment in social phobia. J. Clin. Psychiatry, 55:1994;322-331.
23. Schneier F.R., Davies S.O., Goetz D., et al., A controlled trial of moclobemide in social phobia. Presented at the 1996 Annual Meeting of the American Psychiatric Association; May 8, 1996; New York, NY.
24. Stein M.B., Chartier M.J., Hazen A.L.et al. Paroxetine in the treatment of generalized social phobia: open-label treatment and double-blind placebo-controlled discontinuation. J. Clin. Psychopharmacol. 16:1996;218-222.
25. Tancer M.E. Neurobiology of social phobia. J. Clin. Psychiatry. 54S:1993;26-30.
26. Van Ameringen M., Mancini C., Streiner D.L. Fluoxetine efficacy in social phobia. J. Clin. Psychiatry. 54:1993;27-32.
27. Van Ameringen M., Mancini C., Streiner D.L. Sertraline efficacy in social phobia. J. Affect. Disord. 31:1994;141-145.
28. van Vliet I.M., den Boer Westenberg H.G.M. Psychopharmacologic treatment of social phobia: clinical and biochemical effects of brofaromine, a selective MAO-A inhibitor. Eur. Neuropsychopharmacol. 2:1992;21-29.
29. van Vliet I.M., den Boer J.A., Westenberg H.G.M. Psychopharmacological treatment of social phobia; a double-blind placebo controlled study with fluvoxamine. Psychopharmacology. 115:1994;128-134.
30. Versiani M., Nardi A.E., Mundim F.D.et al. Pharmacotherapy of social phobia: a controlled study with moclobemide and phenelzine. Br. J. Psychiatry. 161:1992;353-360.